Can a digital coach help you avoid heart disease? new study aims to find out

NCT ID NCT07551960

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a digital health platform called STELA that creates personalized lifestyle plans to reduce risk factors for heart disease, like obesity, high cholesterol, and insulin resistance. About 100 adults without existing heart disease will use the platform for a year, receiving e-learning modules, health coaching, and referrals to specialists. The goal is to see if the platform improves an overall health score and is practical for everyday use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

STELA Digital Preventive Medicine Platform (behavioral intervention)

What this could lead to

If successful, this could provide an effective, scalable digital tool for preventing heart disease and related conditions in adults.

What could go wrong

This is a small, early pilot study with no control group, so results may not prove the platform works better than standard care. Success depends on participants sticking with the program.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome Dyslipidemias hyperlipidemia inherited lipid metabolism disorder Insulin Resistance metabolic syndrome X Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Center for Preventive Medicine, Nemocnice AGEL Trinec-Podlesi a.s.

    Třinec, Moravian-Silesian Region, 73961, Czechia